---
title: "TPLC, Total Product Lifecycle | MedTech Terms"
description: "FDA framework integrating premarket and post-market oversight across a device's life. Plain-English Software &amp; AI definition for MedTech teams, with examples an"
lang: en
json-ld: |
  {
    "@context": "https://schema.org",
    "@graph": [
      {
        "@type": "DefinedTerm",
        "@id": "https://medtechterms.com/terms/tplc#term",
        "name": "Total Product Lifecycle",
        "alternateName": "TPLC",
        "description": "TPLC treats premarket review, post-market surveillance, manufacturing controls, and software updates as a connected continuum rather than discrete events. The TPLC database links 510(k), PMA, recall, MDR, and inspection data per device type.",
        "url": "https://medtechterms.com/terms/tplc",
        "termCode": "tplc",
        "inDefinedTermSet": {
          "@type": "DefinedTermSet",
          "name": "MedTech Terms",
          "url": "https://medtechterms.com/terms"
        }
      },
      {
        "@type": "Article",
        "@id": "https://medtechterms.com/terms/tplc#article",
        "headline": "TPLC, Total Product Lifecycle",
        "description": "FDA framework integrating premarket and post-market oversight across a device's life.",
        "url": "https://medtechterms.com/terms/tplc",
        "mainEntityOfPage": {
          "@type": "WebPage",
          "@id": "https://medtechterms.com/terms/tplc"
        },
        "about": {
          "@id": "https://medtechterms.com/terms/tplc#term"
        },
        "articleSection": "Software & AI",
        "inLanguage": "en",
        "keywords": "Total Product Lifecycle, TPLC, Software & AI, medical device, MedTech",
        "author": {
          "@type": "Person",
          "name": "Christian Espinosa",
          "jobTitle": "Founder, Blue Goat Cyber",
          "url": "https://bluegoatcyber.com"
        },
        "publisher": {
          "@type": "Organization",
          "name": "MedTech Terms",
          "url": "https://medtechterms.com"
        },
        "isPartOf": {
          "@type": "WebSite",
          "name": "MedTech Terms",
          "url": "https://medtechterms.com"
        },
        "datePublished": "2026-05-05",
        "dateModified": "2026-05-05",
        "citation": [
          {
            "@type": "CreativeWork",
            "name": "TPLC Database",
            "url": "https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfTPLC/tplc.cfm",
            "publisher": {
              "@type": "Organization",
              "name": "FDA"
            }
          },
          {
            "@type": "CreativeWork",
            "name": "MDCG Software Guidance",
            "url": "https://health.ec.europa.eu/medical-devices-sector/new-regulations/guidance-mdcg-endorsed-documents-and-other-guidance_en",
            "publisher": {
              "@type": "Organization",
              "name": "MDCG"
            }
          },
          {
            "@type": "CreativeWork",
            "name": "FDA - Software as a Medical Device (SaMD)",
            "url": "https://www.fda.gov/medical-devices/digital-health-center-excellence/software-medical-device-samd",
            "publisher": {
              "@type": "Organization",
              "name": "FDA"
            }
          }
        ],
        "mentions": [
          {
            "@type": "DefinedTerm",
            "@id": "https://medtechterms.com/terms/ai-ml-pccp#term",
            "name": "Predetermined Change Control Plan",
            "alternateName": "PCCP",
            "url": "https://medtechterms.com/terms/ai-ml-pccp"
          },
          {
            "@type": "DefinedTerm",
            "@id": "https://medtechterms.com/terms/post-market-surveillance#term",
            "name": "Post-Market Surveillance",
            "alternateName": "PMS",
            "url": "https://medtechterms.com/terms/post-market-surveillance"
          }
        ]
      },
      {
        "@type": "BreadcrumbList",
        "itemListElement": [
          {
            "@type": "ListItem",
            "position": 1,
            "name": "Home",
            "item": "https://medtechterms.com/"
          },
          {
            "@type": "ListItem",
            "position": 2,
            "name": "Terms",
            "item": "https://medtechterms.com/terms"
          },
          {
            "@type": "ListItem",
            "position": 3,
            "name": "Software & AI",
            "item": "https://medtechterms.com/terms?cat=Software%20%26%20AI"
          },
          {
            "@type": "ListItem",
            "position": 4,
            "name": "Total Product Lifecycle",
            "item": "https://medtechterms.com/terms/tplc"
          }
        ]
      },
      {
        "@type": "FAQPage",
        "@id": "https://medtechterms.com/terms/tplc#faq",
        "mainEntity": [
          {
            "@type": "Question",
            "name": "Why is TPLC particularly relevant for AI/ML devices?",
            "acceptedAnswer": {
              "@type": "Answer",
              "text": "AI/ML devices can adapt and learn from real-world data, meaning their performance may change after initial market authorization. TPLC provides a framework for continuously monitoring and managing these changes, ensuring ongoing safety and effectiveness."
            }
          },
          {
            "@type": "Question",
            "name": "How does TPLC affect software updates for medical devices?",
            "acceptedAnswer": {
              "@type": "Answer",
              "text": "Under TPLC, software updates are not isolated events but are considered within the broader context of the device's lifecycle. This requires a systematic approach to assessing the impact of updates on safety, performance, and regulatory compliance, as outlined in documents like the FDA's "
            }
          },
          {
            "@type": "Question",
            "name": "What is the role of post-market surveillance in TPLC?",
            "acceptedAnswer": {
              "@type": "Answer",
              "text": "Post-market surveillance is a critical component of TPLC, involving the collection and analysis of real-world performance data. This data informs risk management, identifies potential issues, and guides necessary modifications or updates to the device."
            }
          }
        ]
      }
    ]
  }
---

[

MedTech Terms

The authoritative reference



](/)

Browse

Learn

[Latest](/latest)

About

1.  [Home](/)
2.  /
3.  [Terms](/terms)
4.  /
5.  [Software & AI](/terms?cat=Software%20%26%20AI)
6.  /
7.  Total Product Lifecycle

[All terms](/terms)

Software & AI [Software Lifecycle](/ecosystems/software-lifecycle)[Global Markets](/ecosystems/global-markets)TPLC 

# Total Product Lifecycle

FDA framework integrating premarket and post-market oversight across a device's life.

Reviewed by [Christian Espinosa, Founder, Blue Goat Cyber](/authors/christian-espinosa) Last reviewed May 5, 2026 

## Definition

TPLC treats premarket review,  [post-market surveillance](/terms/post-market-surveillance), manufacturing controls, and software updates as a connected continuum rather than discrete events. The TPLC database links 510(k),  [PMA](/terms/pma), recall,  [MDR](/terms/mdr-reporting), and inspection data per device type. 

What the regulation says

The FDA emphasizes TPLC in its guidance for Artificial Intelligence/Machine Learning (AI/ML)-enabled medical devices, viewing it as crucial for ensuring safety and effectiveness throughout the device's entire existence. This approach integrates premarket and postmarket activities, recognizing that device performance may evolve, particularly with adaptive AI/ML algorithms. The FDA’s "Guidance for Content of Premarket Submissions for Device Software Functions" further underlines the importance of managing device software throughout its lifecycle, including updates and modifications. 

## What this means in practice

Especially central to AI/ML devices, where post-market performance monitoring and  [PCCP](/terms/ai-ml-pccp)\-driven updates are part of the regulatory lifecycle. 

## Examples

-   An AI-powered diagnostic tool for radiology continually monitors its performance in clinical use, and when new data indicates a potential bias, the manufacturer uses the TPLC framework to update the algorithm and resubmit for regulatory review.
-   A continuous glucose monitor with an AI algorithm receives a software update to improve accuracy, and the manufacturer, following TPLC principles, documents the validation, risk assessment, and regulatory submission for the change.
-   After several years on the market, a surgical robot's software is completely re-architected to incorporate new features, necessitating a comprehensive TPLC review of the design, verification, and validation, similar to an initial market submission.

Common pitfalls

-   • A common pitfall is treating premarket approval as the end of regulatory oversight, rather than an ongoing process, especially for rapidly evolving technologies like AI/ML. Another mistake is failing to integrate post-market surveillance data effectively into product development and risk management processes. Companies often underestimate the resources required for continuous monitoring and updates throughout the product's entire lifecycle. 
-   • Overlooking the need for a robust change management process for software updates can lead to regulatory non-compliance. 
-   • Failing to maintain traceability between software versions, risk assessments, and clinical performance data is a significant pitfall. 

## Frequently asked questions

Why is TPLC particularly relevant for AI/ML devices? 

AI/ML devices can adapt and learn from  [real-world data](/terms/rwd), meaning their performance may change after initial market authorization. TPLC provides a framework for continuously monitoring and managing these changes, ensuring ongoing safety and effectiveness. 

How does TPLC affect software updates for medical devices? 

What is the role of post-market surveillance in TPLC? 

## Cross-references

### See also

Closely related context worth reading.

-   [
    
    AI/ML-Enabled Medical Device
    
    
    
    ](/terms/ai-ml-device)

## Related terms

Grouped by theme 

### Editor's picks

· Hand-selected related concepts 

[

Software & AI

Predetermined Change Control Plan(PCCP) 

FDA mechanism to pre-authorize specific modifications to AI/ML-enabled devices.





](/terms/ai-ml-pccp)[

Post-Market

Post-Market Surveillance(PMS) 

Activities to monitor device safety and performance after market release.





](/terms/post-market-surveillance)

### More in Software & AI

· Same category 

[

Software & AI

AAMI TIR45(TIR45) 

AAMI Technical Information Report providing guidance on applying Agile software development practices within an IEC 62304-compliant medical device software lifecycle.





](/terms/aami-tir45)[

Software & AI

Adversarial Robustness

Resilience of an ML model to inputs deliberately crafted to cause misclassification.





](/terms/adversarial-robustness)[

Software & AI

AI/ML-Enabled Medical Device

Medical device that uses artificial intelligence or machine learning to perform its intended use.





](/terms/ai-ml-device)[

Software & AI

Algorithm Change Protocol(ACP) 

The detailed procedural section of a PCCP that specifies how planned modifications to an AI/ML model will be developed, validated, and implemented.





](/terms/algorithm-change-protocol)

Cited by

Where this term appears across MedTech Terms.

Ecosystems (2)

-   [Software Lifecycle](/ecosystems/software-lifecycle)
-   [Global Markets](/ecosystems/global-markets)

## Primary references

3 sources 

Link health:  3 verified · last checked 2026-06-20 

FDA· 2 MDCG· 1 

1.  [1 
    
    TPLC Database
    
    Verified 
    
    FDA · accessdata.fda.gov 
    
    
    
    ](https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfTPLC/tplc.cfm)
2.  [2 
    
    MDCG Software Guidance
    
    Verified 
    
    MDCG · health.ec.europa.eu 
    
    
    
    ](https://health.ec.europa.eu/medical-devices-sector/new-regulations/guidance-mdcg-endorsed-documents-and-other-guidance_en)
3.  [3 
    
    FDA - Software as a Medical Device (SaMD)
    
    Verified 
    
    FDA · fda.gov 
    
    
    
    ](https://www.fda.gov/medical-devices/digital-health-center-excellence/software-medical-device-samd)

Inline markers like \[1\]  jump to the matching reference above.

Sponsor note

### Building software-as-a-medical-device?

We help SaMD and AI/ML device teams meet IEC 62304 and the FDA's evolving expectations for software cybersecurity.

[Book a 30-minute discovery session](https://go.bluegoatcyber.com/meetings/blue-goat-cyber/discovery-session)

-   No obligation
-   Expert-led from minute one
-   NDA available on request

MedTech Terms is a community resource sponsored by [Blue Goat Cyber](https://bluegoatcyber.com). Definitions are independent of any vendor.

On this term

Category

Software & AI

Acronym

TPLC

Sources

3

Updated

5/5/2026

[Compare with another term](/compare?a=tplc)

Learn in 60 seconds

Card Lesson Quiz

FDA framework integrating premarket and post-market oversight across a device's life.

-   · Especially central to AI/ML devices, where post-market performance monitoring and PCCP-driven updates are part of the regulatory lifecycle. 
-   · The TPLC database links 510(k), PMA, recall, MDR, and inspection data per device type. 

Remember this

Watch out: A common pitfall is treating premarket approval as the end of regulatory oversight, rather than an ongoing process, especially for rapidly evolving technologies like AI/ML. Another mistake is failing to integrate post-market surveillance data effectively into product development and risk management processes. Companies often underestimate the resources required for continuous monitoring and updates throughout the product's entire lifecycle.

Related terms

-   [Predetermined Change Control Plan(PCCP) ](/terms/ai-ml-pccp)
-   [Post-Market Surveillance(PMS) ](/terms/post-market-surveillance)

You may also need

Auto-suggested from Software & AI and shared keywords.

-   [Modular PMA ](/terms/pma-modular)
-   [EU AI Act ](/terms/eu-ai-act)
-   [AAMI TIR45(TIR45) ](/terms/aami-tir45)
-   [Medical Device Data System(MDDS) ](/terms/mdds)
-   [Software Maintenance Plan ](/terms/software-maintenance-plan)
-   [Medical Device User Fee Amendments(MDUFA) ](/terms/mdufa)

[All Software & AI terms](/terms?cat=Software%20%26%20AI)

From the Blue Goat network

Related resources and services on this topic.

-   [
    
    AI SaMD Insights 
    
    How AI is changing SaMD - risk, regulation, and good machine-learning practice.
    
    ](https://ai-samd.com)
-   [
    
    Med Device Cyber Podcast 
    
    Conversations with medical device cybersecurity practitioners.
    
    ](https://mdcpodcast.com)

MedTech Terms 

An authoritative, plain-language reference for the regulatory, quality, cybersecurity, and software terms that shape modern medical devices.

Browse

-   [All terms](/terms)
-   [A–Z index](/a-z)
-   [Categories](/categories)
-   [Ecosystems](/ecosystems)
-   [Learning paths](/paths)
-   [Compare terms](/compare)
-   [Quiz](/quiz)

Resources

-   [FDA Medical Devices](https://www.fda.gov/medical-devices)
-   [EU MDR](https://eur-lex.europa.eu/eli/reg/2017/745/oj)
-   [IMDRF](https://www.imdrf.org/)
-   [Methodology](/methodology)
-   [Changelog](/changelog)
-   [Editor: Christian Espinosa](/authors/christian-espinosa)
-   [About this site](/about)

© 2026 MedTech Terms. Reference content for educational purposes - not regulatory advice. A community resource sponsored by [Blue Goat Cyber](https://bluegoatcyber.com)